Study of Aspirin in Patients With Vestibular Schwannoma
This is a phase II prospective, randomized, double-blind, longitudinal study evaluating whether the administration of aspirin can delay or slow tumor growth and maintain or improve hearing in VS patie...
Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma
This trial will evaluate the safety and tolerability of a single unilateral administration of one of three dose levels of AAVAnc80-antiVEGF and will evaluate the Akouos delivery device to safely achie...
Top Cities for Acoustic Neuroma Clinical Trials
Acoustic Neuroma clinical trials are recruiting across 9 cities. Here are the cities with the most active studies:
About Acoustic Neuroma
Acoustic neuroma (vestibular schwannoma) is a non-cancerous, slow-growing tumor on the nerve connecting the ear to the brain. It can cause hearing loss, tinnitus, and balance problems. Treatment options include observation, surgery, and stereotactic radiosurgery.
Clinical trials are advancing new treatments for acoustic neuroma. Currently, 2 studies are recruiting a combined 327 participants across the United States. Research is being conducted by 2 organizations including Massachusetts Eye and Ear Infirmary, Akouos, Inc..
2026 Acoustic Neuroma Research Landscape
As of March 2026, the acoustic neuroma clinical trial landscape includes 2 actively recruiting studies across 9 cities in the United States. These studies are collectively seeking 327 participants, with an average enrollment target of 164 per study.
Research is being led by 2 different organizations, including Massachusetts Eye and Ear Infirmary, Akouos, Inc..
Geographically, acoustic neuroma trials are most concentrated in Rochester, Minnesota (2 trials); Stanford, California (1 trial); Miami, Florida (1 trial); Iowa City, Iowa (1 trial); Boston, Massachusetts (1 trial) and 4 other cities.
Featured Acoustic Neuroma Studies
Highlighted recruiting studies for acoustic neuroma, selected by enrollment size and research scope.
Study of Aspirin in Patients With Vestibular Schwannoma
This is a phase II prospective, randomized, double-blind, longitudinal study evaluating whether the administration of aspirin can delay or slow tumor growth and maintain or improve hearing in VS patients.
Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma
This trial will evaluate the safety and tolerability of a single unilateral administration of one of three dose levels of AAVAnc80-antiVEGF and will evaluate the Akouos delivery device to safely achieve the intended product performance.
Frequently Asked Questions About Acoustic Neuroma Clinical Trials
Are there acoustic neuroma clinical trials near me?
Yes, there are 2 acoustic neuroma clinical trials currently recruiting across 9+ cities in the United States, including Rochester, Minnesota; Stanford, California; Miami, Florida. Browse the studies above to find one at a location convenient for you.
How do I join a acoustic neuroma clinical trial?
To join a acoustic neuroma clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are acoustic neuroma clinical trials free?
Yes, participation in acoustic neuroma clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of acoustic neuroma treatments are being studied?
Current acoustic neuroma clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 2 research organizations.
Is it safe to participate in acoustic neuroma clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated March 1, 2026 from ClinicalTrials.gov
About This Data
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated March 1, 2026 · Data from ClinicalTrials.gov